decreased creatinine clearance_Vav3<tm1Xrb>/Vav3<tm1Xrb>

http://metadb.riken.jp/0005558NSVav3tm1XrbVav3tm1XrbVav3tm1Xrb

decreased creatinine clearance_Vav3<tm1Xrb>/Vav3<tm1Xrb>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• vav 3 oncogene
  http://metadb.riken.jp/db/mgi_rdf/MGI:1888518

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Vav3<tm1Xrb>/Vav3<tm1Xrb>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Vav3<tm1Xrb>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• Not Specified

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased creatinine clearance
  http://purl.obolibrary.org/obo/MP_0005558

文献

http://purl.org/net/cito/citesAsAuthority

• Vincent. Sauzeau, et.al., Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction., Nature medicine, 2006, 12
  http://rdf.ncbi.nlm.nih.gov/pubmed/16767097